by admin | May 14, 2024 | Blog
Microarray technologies have the potential to add significant value to the field of clinical diagnostics. This powerful technology is high-throughput and sensitive, allowing for the rapid screening of many genetic markers in parallel. In this blog post, we explore how...
by admin | Mar 27, 2024 | News
QuantuMDx are delighted to have been awarded the Outstanding Achievement Award sponsored by Abacus at the 2024 Medilink Healthcare Business Awards. This award was for the Q-POC point of care PCR platform. It was a great evening with some truly inspiring stories....
by QuantuMDx Team | Jun 17, 2022 | News
NEWCASTLE UPON TYNE, UK, [17 June 2022. QuantuMDx Group Limited (“QuantuMDx”), a UK-based developer of transformational Point of Care diagnostics, is pleased to announce that Q-POC™ has made the SelectScientists’ Choice Awards shortlist for the Best New Clinical...
by QuantuMDx Team | May 26, 2022 | News
New multiplex panel can detect SARS-CoV-2, Flu A, Flu B & RSV at the Point of Care Accurate PCR results delivered in approximately 30 minutes NEWCASTLE UPON TYNE, UK, 26 May 2022. QuantuMDx Group Limited (‘QuantuMDx’ or the ‘Company’), a UK-based...
by QuantuMDx Team | May 10, 2022 | Blog
For the first time in three years, it appears we can look forward to a summer where we might feel more relaxed about respiratory viruses. Nonetheless, healthcare services are bracing themselves for what might be an extremely challenging autumn and winter. After two...
